Ingeborg Meijer

867 total citations
35 papers, 584 citations indexed

About

Ingeborg Meijer is a scholar working on Economics and Econometrics, Management Science and Operations Research and Genetics. According to data from OpenAlex, Ingeborg Meijer has authored 35 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 6 papers in Management Science and Operations Research and 6 papers in Genetics. Recurrent topics in Ingeborg Meijer's work include Virus-based gene therapy research (6 papers), scientometrics and bibliometrics research (5 papers) and Innovation Policy and R&D (4 papers). Ingeborg Meijer is often cited by papers focused on Virus-based gene therapy research (6 papers), scientometrics and bibliometrics research (5 papers) and Innovation Policy and R&D (4 papers). Ingeborg Meijer collaborates with scholars based in Netherlands, United Kingdom and Spain. Ingeborg Meijer's co-authors include Gunnar Sivertsen, Detlef Güssow, Hidde L. Ploegh, G. Seemann, Johannes L. Bos, Alex J. van der Eb, Hans van Dam, Peter Herrlich, Alida M.M. Smits and Rienk Offringa and has published in prestigious journals such as Science, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Ingeborg Meijer

31 papers receiving 562 citations

Peers

Countries citing papers authored by Ingeborg Meijer

Since Specialization

Citations

This map shows the geographic impact of Ingeborg Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingeborg Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingeborg Meijer more than expected).

Fields of papers citing papers by Ingeborg Meijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingeborg Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingeborg Meijer. The network helps show where Ingeborg Meijer may publish in the future.

Co-authorship network of co-authors of Ingeborg Meijer

This figure shows the co-authorship network connecting the top 25 collaborators of Ingeborg Meijer. A scholar is included among the top collaborators of Ingeborg Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingeborg Meijer. Ingeborg Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of left atrial appendage amputation in cardiac surgery patients without atrial fibrillation 2025 ·Heart Rhythm ·(unknown), Martijn H. van der Ree, Jolien Neefs, Nicoline W.E. van den Berg, (unknown), Ingeborg Meijer, Zhenyu Dong, Nerea Arrarte Terreros, Wim Jan van Boven, Jonas S.S.G. de Jong, Bart P. van Putte, Antoine H.G. Driessen, Lucas V.A. Boersma, Joris R. de Groot	0
2	Using contribution mapping to evaluate the research impact of Universities of Applied Sciences 2024 ·Research Evaluation ·(unknown), (unknown), Ingeborg Meijer	0
3	Evaluation of research proposals by peer review panels: broader panels for broader assessments? 2023 ·Science and Public Policy ·(unknown), (unknown), (unknown), Ingeborg Meijer	6
4	Local changes in conduction velocity in the left atrium of atrial fibrillation patients undergoing pulmonary vein isolation 2023 ·European Heart Journal ·Ingeborg Meijer, (unknown), (unknown), Chenxi Jiang, Changsheng Ma, Óscar Cámara, Henk A. Marquering, Nerea Arrarte Terreros, Joris R. de Groot	1
5	The Societal Readiness Thinking Tool: A Practical Resource for Maturing the Societal Readiness of Research Projects 2022 ·Science and Engineering Ethics ·Michael J. Bernstein, Mathias Wullum Nielsen, (unknown), (unknown), (unknown), (unknown), Erich Grießler, Stefan de Jong, (unknown), Ingeborg Meijer, Emad Yaghmaei, (unknown), Mika Nieminen, Peter Novitzky, Niels Mejlgaard	19
6	Towards Evaluating the Research Impact made by Universities of Applied Sciences 2021 ·Science and Public Policy ·(unknown), Ingeborg Meijer	9
7	Improve alignment of research policy and societal values 2020 ·Science ·Peter Novitzky, Michael J. Bernstein, Vincent Blok, Róbert Braun, (unknown), Wout Lamers, Anne Loeber, Ingeborg Meijer, Ralf Lindner, Erich Grießler	53
8	“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease 2019 ·Orphanet Journal of Rare Diseases ·(unknown), Anna Ambrosini, Rosaline C. M. Quinlivan, Valeria Sansone, Ingeborg Meijer, Guus Schrijvers, Aad Tibben, George W. Padberg, Maarten de Wit, Ellen Sterrenburg, Alexandre Méjat, (unknown), (unknown), Hanns Lochmüller, (unknown)	11
9	“The impact of European Neuromuscular Centre (ENMC) workshops on the neuromuscular field; 25 years on …” 2019 ·Neuromuscular Disorders ·(unknown), Raffaella Willmann, George W. Padberg, Ellen Sterrenburg, Ingeborg Meijer	3
10	The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, January 19-20, 2018 2019 ·Journal of Neuromuscular Diseases ·Hanns Lochmüller, (unknown), Anna Ambrosini, Baziel G.M. van Engelen, Mats Hansson, Aad Tibben, (unknown), Ellen Sterrenburg, Guus Schrijvers, Ingeborg Meijer, George W. Padberg, Holly L. Peay, Lucía Monaco, Mike Snape, (unknown), Elena Mazzone, Nathalie Bere, (unknown), Erik Landfeldt, Raffaella Willmann	8
11	Improving the evaluation of worldwide biomedical research output: classification method and standardised bibliometric indicators by disease 2018 ·BMJ Open ·(unknown), (unknown), Ludo Waltman, Ingeborg Meijer, Anshu Gupta, Niels Hagenaars	5
12	Unwrapping “impact” for evaluation : A co-word analysis of the UK REF2014 policy documents using VOSviewer 2014 ·Lancaster EPrints (Lancaster University) ·Gemma Derrick, Ingeborg Meijer, (unknown)	6
13	The value of research data metrics for datasets from a cultural and technical point of view. A knowledge exchange report 2013 ·Leiden Repository (Leiden University) ·Rodrigo Costas, Ingeborg Meijer, (unknown), Paul Wouters	9
14	Societal returns of scientific research - How can we measure it? 2012 ·Leiden Repository (Leiden University) ·Ingeborg Meijer	3
15	Societal output and use of research performed by health research groups 2010 ·Health Research Policy and Systems ·(unknown), (unknown), Ingeborg Meijer, (unknown), E.C. Klasen	32
16	From Britney Spears to Erasmus: Women, men and representation 2002 ·Ingeborg Meijer, (unknown)	3
17	Reduced binding activity of transcription factor NF-κB accounts for MHC class I repression in adenovirus type 12 E1-transformed cells 1992 ·Cellular Immunology ·Ingeborg Meijer, (unknown), (unknown), A. Zantema, Alex J. van der Eb	27
18	Co-regulated expression of junB and MHC class I genes in adenovirus-transformed cells. 1991 ·PubMed ·Ingeborg Meijer, Hans van Dam, (unknown), Bos Jl, A. Zantema, (unknown)	9
19	Differential Effects of the Adenovirus E1A Oncogene on Members of the AP-1 Transcription Factor Family 1990 ·Molecular and Cellular Biology ·Hans van Dam, Rienk Offringa, Ingeborg Meijer, Bernd Stein, Alida M.M. Smits, Peter Herrlich, Johannes L. Bos, Alex J. van der Eb	78
20	Adenovirus type 12 E1A down regulates expression of a transgene under control of a major histocompatibility complex class I promoter: evidence for transcriptional control 1989 ·Journal of Virology ·Ingeborg Meijer, A.G. Jochemsen, (unknown), Johannes L. Bos, D. Morello, A.J. van der Eb	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact